WikiMD's WELLNESSPEDIA
WikiMD's WELLNESSPEDIA
Search
Log in
↓
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Navigation menu
Navigation
Main page
Current events
Recent changes
Popular pages
Random page
Upload file
Special pages
WikiMD St@tistics
Wellness matters
Wellness
Diet
Recipes
Weight loss diet
Encyclopedia
Health encyclopedia
Disease index
Health topics
Glossaries
Rare diseases
Sister projects
Christian Encyclopedia
Sponsors
W8MD weight loss centers
Budget GLP1 shots NYC
Philadelphia medical weight loss
Contact
Contact us
Navigation
Speci@l PageS
Editing
MAPK1
From WikiMD's WELLNESSPEDIA
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
'''MAPK1''' (Mitogen-Activated Protein Kinase 1), also known as ERK2 (Extracellular Signal-Regulated Kinase 2), is a crucial enzyme in the [[MAPK/ERK pathway]], which plays a significant role in various cellular processes including proliferation, differentiation, and survival. This kinase is part of the [[Mitogen-Activated Protein Kinase]] (MAPK) family, a group of serine/threonine-specific protein kinases that respond to extracellular stimuli and regulate various cellular activities. == Function == MAPK1 is activated by [[MEK1]] and [[MEK2]], which are themselves activated by upstream [[Ras]] proteins. Upon activation, MAPK1 phosphorylates a number of downstream targets, including various transcription factors, leading to changes in gene expression. This pathway is critical for the control of cell cycle progression and has been implicated in the response to growth factors, [[Oncogenes|oncogenic]] signals, and [[Cytokines|cytokines]]. == Clinical Significance == Alterations in the MAPK/ERK pathway, including mutations in MAPK1, have been associated with a variety of human diseases, particularly [[Cancer|cancers]]. Because of its central role in cell proliferation and survival, MAPK1 is considered a potential target for cancer therapy. Inhibitors of MAPK1 and its upstream activators are currently being explored as therapeutic agents in cancer treatment. == Research == Research on MAPK1 has also highlighted its role in non-cancerous conditions, such as [[Cardiovascular diseases]], [[Neurodegenerative diseases]], and [[Diabetes]]. Understanding the precise mechanisms by which MAPK1 contributes to these diseases is an area of active investigation, with the goal of developing targeted therapies that can modulate this pathway for therapeutic benefit. == See Also == * [[Protein kinase]] * [[Signal transduction]] * [[Cell cycle]] * [[Apoptosis]] == References == <references/> [[Category:Signal transduction]] [[Category:Protein kinases]] [[Category:Cell biology]] {{Molecular-biology-stub}} {{No image}} __NOINDEX__
Summary:
Please note that all contributions to WikiMD's WELLNESSPEDIA are considered to be released under the CC By SA 4.0 (see
WikiMD:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Article stub box
(
edit
)
Template:Asbox
(
edit
)
Template:Hlist/styles.css
(
edit
)
Template:Molecular-biology-stub
(
edit
)
Template:No image
(
edit
)
Module:Arguments
(
edit
)
Module:Article stub box
(
edit
)
Module:Article stub box/styles.css
(
edit
)
Module:Buffer
(
edit
)
Module:Navbar
(
edit
)
Module:Navbar/configuration
(
edit
)
Module:Navbar/styles.css
(
edit
)